Patients who do not respond to clotting factors because they have formed antibodies undergo plasmapheresis. Their plasma is removed and treated to remove the inhibitor and then returned to the patient. This method is combined with immunosuppressive treatment and high doses of clotting factor to prevent further antibody production.
|Effective start/end date||1/10/87 → 30/09/90|
- National Center for Research Resources
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.